MSLN and Hepatic fibrosis: When the composition of myofibroblasts was analyzed in livers of patients with liver fibrosis, the expression of MSLN and THY-1 was upregulated in livers of PSC patients, patients with biliary atresia, and biliary cirrhosis (but not in livers of patients with HCV liver fibrosis).